Results 271 to 280 of about 1,128,759 (377)

(2'-5') oligo adenylate synthetase activity in leucocytes of patients with inflammatory bowel disease. [PDF]

open access: bronze, 1985
Ruth Stalnikowicz   +4 more
openalex   +1 more source

Homeostasis of Gut Microbiota Protects against Susceptibility to Fungal Pneumonia

open access: yesAdvanced Science, EarlyView.
Fungal pneumonia induces inflammation, shown by heightened IL‐6, IL‐1β, TNF‐α levels and a growth in Staphylococcus in the alveolar flora. The gut microbiota, acting through the gut‐lung axis via blood, impacts fungal pneumonia susceptibility by altering lung metabolism and inflammatory responses.
Jian Ji   +12 more
wiley   +1 more source

Histologic and Endoscopic Findings Are Highly Correlated in a Prospective Cohort of Patients With Inflammatory Bowel Diseases. [PDF]

open access: yesJ Crohns Colitis
Di Vincenzo F   +10 more
europepmc   +1 more source

Targeting Intratumoral Copper Inhibits Tumor Progression via p62‐Mediated EZH2 Degradation and Potentiates Anti‐PD‐1 Immunotherapy in Oral Squamous Cell Carcinoma

open access: yesAdvanced Science, EarlyView.
The authors find that by targeting intratumoral copper, they can enhance p62‐mediated ubiquitination of EZH2 at the Ub‐K63 site by suppressing copper binding to SMURF2, an E3 ligase of EZH2, leading to its autophagic degradation. This mechanism suppressed OSCC progression and potentiated anti‐PD‐1 immunotherapy, highlighting a potential new therapeutic
Xiaohu Lin   +9 more
wiley   +1 more source

Effects of inflammatory bowel diseases on sexual function in women. [PDF]

open access: yesIr J Med Sci
Aydamirov M   +4 more
europepmc   +1 more source

Thrombosis as a Complication of Inflammatory Bowel Disease in Children

open access: bronze, 1985
Khazal Paradis   +2 more
openalex   +1 more source

Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases

open access: yesInflammatory Bowel Diseases, 2016
Mei Lan Chen, Mark S. Sundrud
semanticscholar   +1 more source

Carrier‐Free Nanocapsule with Dual‐Target Capacity for Synergistically Restoring Inflammatory Microenvironment and Microbiota Dysbiosis in Colitis

open access: yesAdvanced Science, EarlyView.
This manuscript presents a carrier‐free nanomedicine PCNPs@PEG‐Man with dual‐targeting for IBD. It resists harsh intestinal conditions, reduces oxidative stress, enhances drug uptake and retention, modulates inflammation, and reshapes gut microbiota, offering a safe and effective IBD therapy.
Yingjie Chen   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy